LEUNG GABRIEL
SEC CIK 1236183 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | Dir | 101.1K | — | $422.8K | 12 | 2021-07-06 | 2026-06-03 |
Most active insiders at NVCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DOYLE WILLIAM F | Executive COB, Dir | — | $933.1K |
| 2 | Leonard Frank X | EVP, Pres, Novocure Oncology | — | $919.8K |
| 3 | Paravasthu Mukund | COO | — | $693.8K |
| 4 | Weinberg Uri | Chf Medical, Innovation Ofr | — | $232.2K |
| 5 | Brackmann Christoph | CFO | — | $85.3K |
| 6 | Stafford Kristin | Dir | — | $46.4K |
| 7 | Ocean Allyson J | Dir | — | $46.4K |
| 8 | Scannell Timothy J | Dir | — | $46.4K |
| 9 | VERNON W ANTHONY | Dir | — | $46.4K |
| 10 | Hung David | Dir | — | $46.4K |
| 11 | LEUNG GABRIEL | Dir | — | $46.4K |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-05 16:27 | 2026-06-03 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Dir | A - Grant | $0.00 | +11.6K | 101.1K | +13% | $0 |
| 2026-06-03 16:54 | 2026-06-02 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Dir | S - Sale | $15.77 | -2,945 | 89.5K | -3% | -$46.4K | |
| D | 2025-06-06 | 2025-06-04 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Dir | A - Grant | $0.00 | +11.2K | 92.4K | +14% | $0 |
| 2025-06-04 | 2025-06-03 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Dir | S - Sale | $17.31 | -999 | 81.2K | -1% | -$17.3K | |
| D | 2024-06-06 | 2024-06-05 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Dir | A - Grant | $0.00 | +4,053 | 83.2K | +5% | $0 |
| D | 2024-06-06 | 2024-06-04 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Dir | S - Sale | $23.89 | -964 | 78.2K | -1% | -$23.0K |
| D | 2023-06-09 | 2023-06-07 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Dir | A - Grant | $0.00 | +3,853 | 79.1K | +5% | $0 |
| D | 2022-06-10 | 2022-06-08 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Dir | A - Grant | $0.00 | +2,427 | 75.3K | +3% | $0 |
| D | 2021-08-06 | 2021-08-05 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Dir | M - OptEx | $31.45 | +1,000 | 73.9K | +1% | +$31.4K |
| D | 2021-08-06 | 2021-08-05 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Dir | S - Sale+OE | $152.50 | -1,000 | 72.9K | -1% | -$152.5K |
| D | 2021-07-08 | 2021-07-06 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Dir | S - Sale+OE | $183.54 | -1,000 | 72.9K | -1% | -$183.5K |
| D | 2021-07-08 | 2021-07-06 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Dir | M - OptEx | $31.45 | +1,000 | 73.9K | +1% | +$31.4K |
Purchase Sale Sale after option exercise All abbreviations